Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
The Clinical Biochemist. Reviews|May 26, 2011
Drug dosing in renal diseaseMatthew P Doogue, Thomas M PolasekThe Clinical Biochemist. Reviews|February 19, 2009
Advances in biochemical screening for phaeochromocytoma using biogenic aminesMalcolm J Whiting, Matthew P DoogueAustralian Prescriber|October 30, 2025
Oral anticoagulation for adults with atrial fibrillation or venous thromboembolismPaul Kl Chin, Matthew P DoogueMayo Clinic Proceedings|October 11, 2005
Clopidogrel hypersensitivity syndrome with rash, fever, and neutropeniaMatthew P Doogue, Evan J Begg, Paul BridgmanTherapeutic Advances in Drug Safety|August 2, 2014
Metabolic activation of clopidogrel: in vitro data provide conflicting evidence for the contributions of CYP2C19 and PON1Thomas M Polasek, Matthew P Doogue, John O MinersTherapeutic Advances in Drug Safety|June 2, 2018
Metformin treatment of type 2 diabetes mellitus in pregnancy: update on safety and efficacyThomas M Polasek, Matthew P Doogue, Tilenka R J ThynneBritish Journal of Clinical Pharmacology|April 15, 2021
Drug metabolism in severe chronic obstructive pulmonary disease: A phenotyping cocktail studyRichard P McNeill, Mei Zhang, Michael J Epton, et al.British Journal of Clinical Pharmacology|January 5, 2006
Quantification of infant exposure to celecoxib through breast milkSharon J Gardiner, Matthew P Doogue, Mei Zhang, et al.Annals of Clinical Biochemistry|January 20, 2009
Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalaciaBelinda J Schouten, Matthew P Doogue, Steven G Soule, et al.British Journal of Clinical Pharmacology|January 13, 2011
Perpetrators of pharmacokinetic drug-drug interactions arising from altered cytochrome P450 activity: a criteria-based assessmentThomas M Polasek, Frank P Y Lin, John O Miners, et al.Pageof 4